| 2020 | | Obesity increases the incidence of new-onset lupus nephritis and organ damage during follow-up in patients with systemic lupus erythematosus | 김현아 |
| 2019 | | Plasma Free Protein S Is Correlated with Disease Activity, but not with Subclinical Atherosclerosis among Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study | 김현아, 서창희, 정주양 |
| 2018 | | Polyamine patterns in plasma of patients with systemic lupus erythematosus and fever | 김현아, 서창희, 이광, 정주양 |
| 2019 | | Polymorphisms of MFGE8 are associated with susceptibility and clinical manifestations through gene expression modulation in Koreans with systemic lupus erythematosus | 김현아, 서창희, 정주양 |
| 2010 | | Prevalence of human papilloma virus infections and cervical cytological abnormalities among Korean women with systemic lupus erythematosus. | 김현아, 서창희 |
| 2013 | | Promising biomarkers for systemic lupus erythematosus. | 배창범, 서창희, 정주양 |
| 2011 | | Replicated association of a regulatory polymorphism in the interferon γ gene with lupus susceptibility. | 서창희 |
| 2022 | | S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus | 김지원, 김현아, 서창희, 정주양 |
| 2021 | | Salivary immunoglobulin gamma-3 chain c is a promising noninvasive biomarker for systemic lupus erythematosus | 김현아, 서창희, 정주양 |
| 2024 | | Seasonal vitamin D levels and lupus low disease activity state in systemic lupus erythematosus | 김지원, 김현아, 백욱영, 서창희, 정주양 |
| 2013 | | Serum growth arrest-specific protein 6 levels are a reliable biomarker of disease activity in systemic lupus erythematosus. | 김현아, 서창희, 전자영, 정주양 |
| 2022 | | Successful treatment of thrombotic thrombocytopenic purpura with plasmapheresis and anti-CD20 antibodies in a patient with immune thrombocytopenia and systemic lupus erythematosus: Case report | 김지원, 김현아, 서창희, 정주양 |
| 2003 | | T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice. | 서창희 |
| 2010 | | TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus. | 서창희 |
| 2003 | | The effects of anti-idiotypic antibody on antibody production and apoptosis of anti-dsDNA antibody producing cells. | 서창희 |
| 2013 | | The interleukin 6 receptor alpha gene polymorphisms are associated with clinical manifestations of systemic lupus erythematosus in Koreans. | 김현아, 서창희, 전자영 |
| 2017 | | The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: A STROBE-compliant retrospective observational analysis | 김현아, 서창희, 정주양 |
| 2018 | | The Transcription Factor Ets1 Suppresses T Follicular Helper Type 2 Cell Differentiation to Halt the Onset of Systemic Lupus Erythematosus | 서창희, 정주양 |
| 2016 | | Thrombocytopenia in Systemic Lupus Erythematosus: Clinical Manifestations, Treatment, and Prognosis in 230 Patients | 김현아, 서창희, 정주양 |
| 2021 | | Toll‐like receptor signaling inhibitory peptide improves inflammation in animal model and human systemic lupus erythematosus | 서창희 |
| 2017 | | Usefulness of neutrophil-to-lymphocyte ratio as a biomarker for diagnosing infections in patients with systemic lupus erythematosus | 김현아, 서창희, 정주양 |
| 2012 | | Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries | 서창희 |
| 2011 | | Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus. | 김현아, 서창희 |
